Business Context and Reporting Period
This Form 6-K filing by Silicom Ltd. covers the month of June 2026. The document reports on the outcomes of the Annual General Meeting of Shareholders held on June 3, 2026, and subsequent Board of Directors actions taken on June 23, 2026, regarding executive compensation and auditor appointments.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity for the reporting period. The only financial figure disclosed is a performance threshold for executive equity compensation: consolidated revenues of at least US$83 million for the fiscal year ending December 31, 2026.
Material Changes and Corporate Actions
- Executive Compensation Increases: Shareholders approved retroactive salary increases effective January 1, 2026:
- CEO Liron Eizenman: Increased from NIS 70,000 to NIS 73,850 per month.
- Active Chairman Avi Eizenman: Increased from NIS 102,536 to NIS 108,175 per month.
- Director Re-election: Mr. Yeshayahu ("Shaike") Orbach was re-elected to the Board of Directors for a three-year term.
- Auditor Appointment: Kesselman & Kesselman Certified Public Accountants (Isr.), PwC Israel, were appointed as independent public accountants for the year ending December 31, 2026.
- RSU Grant Override: Shareholders initially rejected proposals to grant 38,333 RSUs to the CEO and 42,000 RSUs to the Chairman. However, the Board and Compensation Committee exercised their right under Israeli law to override this rejection. The CEO's grant was reinstated but modified to include a strict performance-based forfeiture condition.
Outlook, Risks, and Contingencies
Performance Condition: The reinstated RSU grant to the CEO is contingent on the Company achieving consolidated revenues of at least US$83 million for the fiscal year ending December 31, 2026. If this target is not met, the RSUs will be forfeited in their entirety.
Governance Risk: The filing highlights a divergence between shareholder sentiment and Board decisions regarding equity compensation, noting the Board's reliance on Israeli legal provisions to override shareholder rejections.
Investor Verification Checklist
- Verify the Company's current revenue trajectory against the US$83 million threshold required for the CEO's RSU vesting.
- Review the detailed reasons provided by the Compensation Committee and Board for overriding the shareholder rejection of the RSU grants.
- Confirm the total annual cost impact of the approved salary increases for the CEO and Chairman.
- Monitor future filings for any further shareholder dissent regarding the overridden compensation packages.